About Us

Our laboratory uses genetic approaches in live zebrafish embryos and cultured human cancer cells to delineate novels targets for safer and more effective cancer treatments. Read More

SCHOOL OF MEDICINE NEWS

Ketamine Shows Significant Benefit in People with Treatment-Resistant Depression 
May 20, 2013 - Patients with treatment-resistant major depression saw dramatic improvement in their illness after treatment with ketamine, an anesthetic.

 

Degenerative Changes Identified in Spinal Discs and Reversed With Drug Cocktail In Diabetic Mice 
May 17, 2013 - The study, led by James C. Iatridis, PhD, was published in the journal PLOS ONE on May 17.

 

Icahn School of Medicine at Mount Sinai and Bene Pharmachem Gmbh To Collaborate On Clinical Studies For Mucopolysaccharidoses 
May 15, 2013 - The company, based in Germany, is the sole producer of pharmaceutical pentosan polysulfate.

 
VIEW ALL

Samuel Sidi, PhD

Contact Us

Samuel Sidi, PhD
Tel: 212-241-1443
Fax: 646-537-8698
Send e-mail

Annenberg Building
Room 24-16, -19, -28A
1468 Madison Avenue
Box 1079
New York NY 10029

Affiliations
Department of Medicine Division of Hematology/Oncology Department of Developmental and Regenerative Biology Department of Oncological Sciences Tisch Cancer Institute